Related Experiment Video
Updated: May 9, 2026

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
Published on: June 28, 2018
The "Methyl-CpG Binding Domain protein 2" plays a repressive role in relation to the promoter CpG content in the
Laury Perriaud, Joel Lachuer, Robert Dante1
1INSERM U 1052/CNRS UMR 5286, Centre de Recherche en Cancerologie de Lyon (CRCL), Centre Leon Berard. 28, rue Laennec. 69373 Lyon Cedex 08. France. dante@univ-lyon1.fr.
Abstract:
In cancer cells, methylation-dependent gene silencing is at least partly mediated by the "Methyl-CpG-Binding Domain protein 2" (MBD2 protein), via the recruitment of chromatin remodeling complexes. However this repressive role was poorly investigated in normal cells. To identify the genes repressed by MBD2 in these cells, we have determined the impact of MBD2 depletion on gene expression in human embryonic MRC5 fibroblasts, using RNA inference combined with microarray analysis. The up-regulation of some randomly selected genes was confirmed and a direct association between gene repression and MBD2 binding on methylated promoters associated to these genes was subsequently established. This control of gene expression appears to depend on the CpG content of promoters as MBD2 depletion was not sufficient to induce the expression of silent genes associated with High-CpG promoters, but it was required to achieve the methyl-dependent transcriptional locking of the genes associated with promoters exhibiting intermediate CpG content. Therefore, MBD2 seems to play a selective role in gene repression depending on the CpG content of the promoter regions.
Insights
Methyl-CpG-Binding Domain protein 2 (MBD2) represses genes in normal cells by binding methylated promoters. Its role depends on promoter CpG content, selectively silencing genes with intermediate CpG regions.
Area of Science:
- Epigenetics
- Gene Regulation
- Molecular Biology
Background:
- Methylation-dependent gene silencing in cancer involves Methyl-CpG-Binding Domain protein 2 (MBD2).
- The repressive role of MBD2 in normal cells remains under-investigated.
- Understanding MBD2 function in non-cancerous cells is crucial for a complete picture of its biological roles.
Purpose of the Study:
- To identify genes repressed by MBD2 in normal human embryonic fibroblasts (MRC5).
- To investigate the relationship between MBD2 binding, promoter methylation, and gene expression.
- To determine if MBD2's regulatory role is influenced by the CpG content of gene promoters.
Main Methods:
- Utilized RNA inference combined with microarray analysis to assess gene expression changes upon MBD2 depletion.
- Performed MBD2 depletion in human embryonic MRC5 fibroblasts.
- Established direct association between MBD2 binding on methylated promoters and gene repression.
Main Results:
- MBD2 depletion led to the up-regulation of specific genes in MRC5 fibroblasts.
- Confirmed a direct link between MBD2 binding to methylated promoters and gene silencing.
- Demonstrated that MBD2's repressive function is selective, depending on promoter CpG content.
- MBD2 depletion was insufficient to activate genes with High-CpG promoters but was necessary for methyl-dependent silencing of genes with intermediate CpG promoters.
Conclusions:
- MBD2 plays a selective role in gene repression in normal cells, contingent on promoter CpG density.
- MBD2 is essential for the transcriptional locking of genes associated with intermediate CpG promoters.
- These findings highlight a nuanced mechanism of MBD2-mediated gene silencing based on promoter characteristics.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Master Transcription Regulators
Abnormal Proliferation
Co-activators and Co-repressors
Co-activators and Co-repressors

